Dr. Ramon Joson Gomez, M,D, Emergency Medicine Medicare: Medicare Enrolled Practice Location: Danville Regional Medical Center, 142 S. Main Street, Danville, VA 24541 Phone: 434-799-3742 Fax: 434-799-2133 |
Michael G Hickey, P.A. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1402 Main St, Drmc Ed, Danville, VA 24145 Phone: 804-287-7066 Fax: 804-673-9531 |
Richard A Smith, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 142 S Main St, Emergency Dept, Danville, VA 24541 Phone: 434-799-3742 Fax: 434-799-3857 |
John J Dallara, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 142 S Main St, Danville, VA 24541 Phone: 919-810-9971 |
Dr. Neil Joseph Lahurd Jr., DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 949 Piney Forest Rd, Danville, VA 24540 Phone: 434-835-4876 |
Reuben De Las Alas, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 142 S Main St, Emergency Dept., Danville, VA 24541 Phone: 434-799-2222 Fax: 434-799-3857 |
News Archive
Representatives from over 20 different healthcare organisations will be convening at the University of Leicester on 11 June to discuss how old patterns of patient safety and historical complaints against doctors are still being replicated in the modern welfare system - and what lessons can be learned by looking to our medical past.
A study led by scientists at the Institute for Research in Biomedicine and published in Nature Communications proposes chaperone protein Hps70 as an attractive therapeutic target for the treatment of Kennedy's disease—a rare neuromuscular condition—and of castration-resistant prostate cancer.
Mattress Firm, a leading specialty mattress retailer with more than 720 stores nationwide, is committed to supporting the fight against pancreatic cancer by raising funds for clinical trials through the Translational Genomics Research Institute (TGen) globalCure initiative.
As the rate of opioid abuse soars to new levels, growing recognition of the problem is garnering unprecedented media attention—as well as motivating innovative new approaches to better treatment.
The National Institutes of Health (NIH) has awarded United Therapeutics Corporation a contract for up to $45 million over five years "to help develop a potential oral treatment for viruses like influenza and the mosquito-borne tropical fever dengue," the Associated Press/Washington Post reports.
› Verified 6 days ago